You have to be signed in to use this resource.
The re-classification and characterisation of CNS primitive neuroectodermal tumours (CNS-PNET)
A really useful research article which uses DNA methylation profiling to re-classify CNS-PNET tumours, and additional molecular techniques to characterise a series of new tumour entities:
1. CNS Neuroblastoma with FOXR2 Activation (CNS NB-FOXR2)
2. CNS Ewing Sarcoma Family Tumor with CIC Alteration (CNS EFT-CIC)
3. CNS High-Grade Neuroepithelial Tumor with MN1 Alteration (CNS HGNET-MN1)
4. CNS High-Grade Neuroepithelial Tumor with BCOR Alteration (CNS HGNET-BCOR)
These now feature in the WHO CNS Tumour Classification 2021.
Resource details
| Contributed by: | Pathology Portal |
| Authored by: |
|
| Licence: | © All rights reserved More information on licences |
| First contributed: | 24 July 2022 |
| Audience access level: | Full user |
Share this resource
Report an issue with this resource
You may report a resource, for example, if there is an issue with copyright infringement, breach of personal data, factual inaccuracies, typing errors or safety concerns. The type of issue will determine whether the resource is immediately removed from the platform or if the contributor is asked to make amendments. You can report a resource from the resource information page or by contacting the Learning Hub support team.
You can contact the Learning Hub support team by completing the support form or if you have a general enquiry you can email enquiries@learninghub.nhs.uk.